These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

769 related items for PubMed ID: 9093141

  • 1. The influence of thrombotic risk factors when oral contraceptives are prescribed. A control-only study.
    Lidegaard O.
    Acta Obstet Gynecol Scand; 1997 Mar; 76(3):252-60. PubMed ID: 9093141
    [Abstract] [Full Text] [Related]

  • 2. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
    Jick SS, Kaye JA, Russmann S, Jick H.
    Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
    [Abstract] [Full Text] [Related]

  • 3. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
    Serfaty D, Wildemeersch D, Verougstraete A, Creatsas G.
    Int J Fertil Menopausal Stud; 1995 Jun; 40 Suppl 2():73-9. PubMed ID: 8574253
    [Abstract] [Full Text] [Related]

  • 4. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD, Lawrenson RA, Thompson CR, Kennedy JG, Hambleton IR.
    Lancet; 1997 Jan 11; 349(9045):83-8. PubMed ID: 8996419
    [Abstract] [Full Text] [Related]

  • 5. Oral contraceptive use and venous thromboembolism: a consideration of the impact of bias and confounding factors on epidemiological studies.
    Rekers H, Norpoth T, Michaels MA.
    Eur J Contracept Reprod Health Care; 1996 Jan 11; 1(1):21-30. PubMed ID: 9678134
    [Abstract] [Full Text] [Related]

  • 6. Oral contraceptives and venous thromboembolism: an epidemiological review.
    Lidegaard O.
    Eur J Contracept Reprod Health Care; 1996 Jan 11; 1(1):13-20. PubMed ID: 9678133
    [Abstract] [Full Text] [Related]

  • 7. Use of oral contraceptives containing gestodene and risk of venous thromboembolism: outlook 10 years after the third-generation "pill scare".
    Heinemann LA, Dinger JC, Assmann A, Minh TD.
    Contraception; 2010 May 11; 81(5):401-7. PubMed ID: 20399946
    [Abstract] [Full Text] [Related]

  • 8. [Oral contraceptives and cerebral thromboembolism. A Danish case-control study].
    Lidegaard O.
    Ugeskr Laeger; 1993 Nov 01; 155(44):3538-45. PubMed ID: 8236574
    [Abstract] [Full Text] [Related]

  • 9. Oral contraceptives and thrombotic disease: risk of venous thromboembolism.
    Helmerhorst FM, Bloemenkamp KW, Rosendaal FR, Vandenbroucke JP.
    Thromb Haemost; 1997 Jul 01; 78(1):327-33. PubMed ID: 9198174
    [Abstract] [Full Text] [Related]

  • 10. Relationship of migraine headache and stroke to oral contraceptive use.
    Benson MD, Rebar RW.
    J Reprod Med; 1986 Dec 01; 31(12):1082-8. PubMed ID: 3540297
    [Abstract] [Full Text] [Related]

  • 11. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
    Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C.
    Lancet; 1995 Dec 16; 346(8990):1589-93. PubMed ID: 7500750
    [Abstract] [Full Text] [Related]

  • 12. [Risk of thromboembolism and oral contraceptives].
    Lê MG.
    Contracept Fertil Sex; 1996 May 16; 24(5):378-83. PubMed ID: 8704816
    [Abstract] [Full Text] [Related]

  • 13. The use of a large-scale surveillance system in Planned Parenthood Federation of America clinics to monitor cardiovascular events in users of combination oral contraceptives.
    Burnhill MS.
    Int J Fertil Womens Med; 1999 May 16; 44(1):19-30. PubMed ID: 10206196
    [Abstract] [Full Text] [Related]

  • 14. Oral contraceptives and venous thromboembolism.
    Paul C.
    N Z Med J; 1996 Nov 08; 109(1033):413-5. PubMed ID: 8941290
    [Abstract] [Full Text] [Related]

  • 15. The Royal College of General Practitioners' Oral Contraception Study: some recent observations.
    Kay CR.
    Clin Obstet Gynaecol; 1984 Dec 08; 11(3):759-86. PubMed ID: 6509858
    [Abstract] [Full Text] [Related]

  • 16. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY, Plu-Bureau G, Zitoun D, Bara L, Guize L, Samama MM.
    Thromb Haemost; 1995 Sep 08; 74(3):928-32. PubMed ID: 8571323
    [Abstract] [Full Text] [Related]

  • 17. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Lancet; 1995 Dec 16; 346(8990):1582-8. PubMed ID: 7500749
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Estrogen and progestin components of oral contraceptives: relationship to vascular disease.
    Carr BR, Ory H.
    Contraception; 1997 May 16; 55(5):267-72. PubMed ID: 9220222
    [Abstract] [Full Text] [Related]

  • 20. Cardiovascular effects of oral contraceptives: a review.
    Stubblefield PG.
    Int J Fertil; 1989 May 16; 34 Suppl():40-9. PubMed ID: 2576258
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.